TRIM21 and dermatomyositis: However, clinical studies have shown that anti‐SSA/Ro52 Abs were associated with ILD19, 20 and DM patients with anti‐MDA5 and anti‐SSA‐52 double positive had a high mortality rate and poor prognosis.19